Enterprise Value
$260.79 M
+$6.90 M+2.72%
Wed, 27 Nov 2024 22:55:39 GMT
Summary:
Galectin Therapeutics enterprise value is currently $260.79 million, with a rise of +$6.90 million (+2.72%) during the most recent trading day. Over the past year, it has increased by +$96.86 million (+59.08%). GALT enterprise value is now -23.68% below its all-time high of $341.72 million.GALT Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +2.7% | +3.9% | +3.9% |
| 1 m1 month | +11.5% | +17.2% | +16.3% |
| 3 m3 months | +11.4% | +10.2% | +9.4% |
| 6 m6 months | +4.9% | -3.3% | -4.3% |
| ytdytd | +75.3% | +78.5% | +75.9% |
| 1 y1 year | +59.1% | +48.9% | +46.7% |
| 5 y5 years | +92.2% | -1.5% | -10.7% |
GALT Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $271 M | -3.7% | $233 M | +12.1% |
| 3 m | 3 months | $271 M | -3.7% | $218 M | +19.6% |
| 6 m | 6 months | $271 M | -3.7% | $186 M | +39.9% |
| 1 y | 1 year | $321 M | -18.8% | $139 M | +87.4% |
| 3 y | 3 years | $321 M | -18.8% | $68 M | +281.5% |
| 5 y | 5 years | $321 M | -18.8% | $39 M | +574.3% |
| alltime | all time | $342 M | -23.7% | -$1 M | >+9999.0% |
Galectin Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $260.79 M(+75.3%) |
| 2023 | $148.80 M(+68.3%) |
| 2022 | $88.43 M(-21.2%) |
| 2021 | $112.24 M(+11.4%) |
| 2020 | $100.75 M(-12.6%) |
| 2019 | $115.28 M(-13.3%) |
| 2018 | $133.03 M(+14.2%) |
| 2017 | $116.48 M(+589.6%) |
| 2016 | $16.89 M(-21.2%) |
| 2015 | $21.43 M(-55.5%) |
| 2014 | $48.17 M(-65.1%) |
| Date | Value |
|---|---|
| 2013 | $138.08 M(+486.0%) |
| 2012 | $23.56 M(-65.4%) |
| 2011 | $68.02 M(+31.8%) |
| 2010 | $51.63 M(+262.6%) |
| 2009 | $14.24 M(+239.2%) |
| 2008 | $4.20 M(-84.4%) |
| 2007 | $26.94 M(+94.3%) |
| 2006 | $13.86 M(-82.4%) |
| 2005 | $78.85 M(+36.9%) |
| 2004 | $57.59 M(-34.2%) |
| 2003 | $87.50 M(+64.2%) |
| 2002 | $53.29 M |
FAQ
- What is Galectin Therapeutics enterprise value?
- What is the all time high enterprise value for Galectin Therapeutics?
- What is GALT enterprise value year-to-date change?
- What is Galectin Therapeutics enterprise value year-on-year change?
What is Galectin Therapeutics enterprise value?
The current enterprise value of GALT is $260.79 M
What is the all time high enterprise value for Galectin Therapeutics?
Galectin Therapeutics all-time high enterprise value is $341.72 M
What is GALT enterprise value year-to-date change?
Galectin Therapeutics enterprise value has changed by +$111.99 M (+75.26%) since the beginning of the year
What is Galectin Therapeutics enterprise value year-on-year change?
Over the past year, GALT enterprise value has changed by +$96.86 M (+59.08%)